How I Treat Diffuse Large B-Cell and Mediastinal Large Cell Lymphomas
Upon viewing this session, you will be able to identify key aspects of DLBCL clinical and prognostic features that affect outcome, recognize which subsets of DLBCL should be managed with regimens other than R-CHOP, and ecome familiar with novel and investigational strategies in DLBCL management.
John P. Leonard, MD, Weill Cornell Medical College
Active, International, Emeritus, and Honorary Members
Associate, International Associate, Student, and Resident Members